TAFI – Thrombin Activatible Fibrinolysis Inhibitor Deficient Plasma

Affinity’s TAFI – Thrombin Activatible Fibrinolysis Inhibitor Deficient Plasma is manufactured from pooled normal human plasma depleted of TAFI using antibodies directed to TAFI. Only the highest quality citrated plasma is used as starting material. Our Frozen Deficient or Depleted Plasma products are typically buffered with the addition of HEPES to 20mM final concentration and our Lyophilized Deficient Plasma products are typically buffered with the addition of HEPES to 50mM final concentration.

All TAFI – Thrombin Activatible Fibrinolysis Inhibitor Deficient Plasma or Depleted Plasma from Affinity Biologicals are for Research Use Only and must not be used for diagnostic applications.